Written question asked by Roger Williams (Liberal Democrat) on Wednesday, 16 March 2005, in the House of Commons. It was due for an answer on Wednesday, 23 March 2005. It was answered by Baroness Winterton of Doncaster (Labour) on Wednesday, 23 March 2005 on behalf of the Department of Health.

Dept of Health

Question: To ask the Secretary of State for Health, if he will make a statement on the recommendation of the National Institute for Clinical Excellence not to use donepezil (Aricept) in the treatment of mild to moderate cases of Alzheimer's disease.

Answer: Mr. Chope: To ask the Secretary of State for Health if he will place in the Library a copy of the Government's response to the consultation by the National Institute for Clinical Excellence on the cost effectiveness of Arisept, Excelon and Reminyl. [222690] Mr. Roger Williams: To ask the Secretary of State for Health if he will make a statement on the recommendation of the National Institute for Clinical Excellence not to use donepezil (Aricept) in the treatment of mild to moderate cases of Alzheimer's disease. [223094] Ms Rosie Winterton: [holding answer 22 March 2005]: I refer the hon. Members to the reply I gave my hon. Friend the Member for Monmouth (Mr. Edwards) on Wednesday 23 March.

Secondary information